Mr. David Harding serves as a member of TransMed7’s Business Advisory Board.
Mr. Harding is currently the SVP of Corporate Strategy and Business Development at Exact Sciences, a diagnostics company focused on colorectal cancer screening. Prior to this role, he was the Chief Commercial Officer at both T2Biosystems, a company focused on innovative approaches to infectious disease testing, and OvaScience, a fertility-oriented biotech. Previously, Mr. Harding held a variety of business unit leadership positions at Hologic over the course of 10 years, culminating in being named Senior Vice President and General Manager of the $1.2 Billion Women’s Health business unit. Prior to Hologic, Mr. Harding was a partner and associate at McKinsey & Company, where he focused on corporate and commercial strategy.
Mr. Harding earned his MBA from the University of Pennsylvania’s Wharton School of Business and his Bachelor of Science in Aerospace Engineering from the University of Southern California.